Kristin is joined by Dr Priya Sumithran, Endocrinologist and Clinician Researcher, to talk about treatment options for the management of type II diabetes. Priya leads the Obesity Research Group at the University of Melbourne, Department of Medicine (St Vincent's) and is Head of Obesity Medicine at Austin Health. *Note Wegovy (semaglutide) was not registered in Australia at the time of recording but has since been registered with the TGA (1st September 2022). PBAC Public Summary Document - Wegovy (semaglutide) - March 2022 consideration
